Literature DB >> 11704657

Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle.

N H Prins1, L M Akkermans, R A Lefebvre, J A Schuurkes.   

Abstract

1. We aimed to characterize the 5-HT receptors involved in the 5-HT-induced effect on electrically induced contractions of dog antrum longitudinal muscle in vitro. 2. In the presence of L-NOARG (0.1 mM), electrical field stimulation (EFS) induced atropine- and tetrodotoxin-sensitive contractions. Tetrodotoxin or atropine left any agonist tested ineffective. These EFS-induced contractions were on average enhanced by 5-HT (0.3 microM), however, pronounced variation in the response to 5-HT was observed. There were non-significant trends of the selective 5-HT3 receptor antagonist granisetron (1 microM), and methysergide (1 microM; preventing interactions of 5-HT with 5-HT1, 5-HT2, 5-ht5, 5-HT6 and 5-HT7 receptors) to increase the response to 5-HT. The selective 5-HT4 receptor antagonist GR 113808 (0.1 microM) displayed a non-significant trend to inhibit the 5-HT-induced increase. 3. Combination experiments with methysergide (1 microM), granisetron (1 microM) and GR 113808 (0.1 microM) revealed that the 5-HT (0.3 microM)-induced response consisted of (1) an excitatory component blocked by GR 113808, (2) excitatory and inhibitory components both blocked by methysergide. 4. The selective 5-HT4 receptor agonist prucalopride (0.3 microM) increased EFS-induced contractions, an effect prevented by GR 113808 (0.1 microM). 5. The increase of EFS-induced contractions by the preferential 5-HT2 receptor agonist alpha-Me-5-HT (0.3 microM) was antagonized by 5-HT2B receptor antagonists. 6. The 5-HT1/5-HT7 receptor agonist 5-carboxamidotryptamine (5-CT; 0.3 microM) inhibited EFS-induced contractions. This was prevented by methysergide (1 microM), the 5-HT7 receptor antagonist mesulergine (0.3 microM) and the selective 5-HT7 receptor antagonist SB-269970 (0.3 microM). 7. In the presence of GR 113808 (0.1 microM), alpha-Me-5-HT (1 microM) increased EFS-induced contractions. The 5-HT (0.3 microM)-induced inhibition of the stimulation by alpha-Me-5-HT was prevented by SB-269970 (0.3 microM). 8. In conclusion, dog antral longitudinal muscle is endowed with (1) excitatory neuronal 5-HT4 receptors and 5-HT2B receptors and (2) inhibitory smooth muscle 5-HT7 receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704657      PMCID: PMC1573064          DOI: 10.1038/sj.bjp.0704376

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Regional difference in correlation of 5-HT4 receptor distribution with cholinergic transmission in the guinea pig stomach.

Authors:  K Takada; Y Sakurai-Yamashita; K Yamashita; M Kaibara; Y Hamada; Y Nakane; K Hioki; K Taniyama
Journal:  Eur J Pharmacol       Date:  1999-06-25       Impact factor: 4.432

2.  A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).

Authors:  P J Lovell; S M Bromidge; S Dabbs; D M Duckworth; I T Forbes; A J Jennings; F D King; D N Middlemiss; S K Rahman; D V Saunders; L L Collin; J J Hagan; G J Riley; D R Thomas
Journal:  J Med Chem       Date:  2000-02-10       Impact factor: 7.446

3.  Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist.

Authors:  J J Hagan; G W Price; P Jeffrey; N J Deeks; T Stean; D Piper; M I Smith; N Upton; A D Medhurst; D N Middlemiss; G J Riley; P J Lovell; S M Bromidge; D R Thomas
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

4.  N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea: a novel, high-affinity 5-HT2B receptor antagonist.

Authors:  I T Forbes; G E Jones; O E Murphy; V Holland; G S Baxter
Journal:  J Med Chem       Date:  1995-03-17       Impact factor: 7.446

5.  5-HT(4) receptors mediating enhancement of contractility in canine stomach; an in vitro and in vivo study.

Authors:  N H Prins; A van Der Grijn; R A Lefebvre; L M Akkermans; J A Schuurkes
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

6.  Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron).

Authors:  G J Sanger; D R Nelson
Journal:  Eur J Pharmacol       Date:  1989-01-10       Impact factor: 4.432

7.  Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.

Authors:  W J de Ridder; J A Schuurkes
Journal:  J Pharmacol Exp Ther       Date:  1993-01       Impact factor: 4.030

8.  SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism.

Authors:  G W Gullikson; M A Virina; R F Loeffler; D C Yang; B Goldstin; S X Wang; C Moummi; D L Flynn; D L Zabrowski
Journal:  J Pharmacol Exp Ther       Date:  1993-01       Impact factor: 4.030

9.  GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor.

Authors:  J D Gale; C J Grossman; J W Whitehead; A W Oxford; K T Bunce; P P Humphrey
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

10.  Antagonism by SB 204070 of 5-HT-evoked contractions in the dog stomach: an in-vivo model of 5-HT4 receptor function.

Authors:  S Bingham; B F King; B Rushant; M I Smith; L Gaster; G J Sanger
Journal:  J Pharm Pharmacol       Date:  1995-03       Impact factor: 3.765

View more
  7 in total

1.  Smooth muscle 5-HT2A receptors mediating contraction of porcine isolated proximal stomach strips.

Authors:  P Janssen; N H Prins; A L Meulemans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Safety and efficacy of cyproheptadine for treating dyspeptic symptoms in children.

Authors:  Leonel Rodriguez; Juan Diaz; Samuel Nurko
Journal:  J Pediatr       Date:  2013-02-16       Impact factor: 4.406

Review 3.  Prucalopride: For functional constipation only?

Authors:  M Bellini; D Gambaccini; G Bassotti
Journal:  Tech Coloproctol       Date:  2016-05-12       Impact factor: 3.781

4.  Pharmacological characterization of the 5-HT receptors mediating contraction and relaxation of canine isolated proximal stomach smooth muscle.

Authors:  P Janssen; N H Prins; A L Meulemans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

5.  Effect of enterokinetic prucalopride on intestinal motility in fast rats.

Authors:  Hui-Bin Qi; Jin-Yan Luo; Xin Liu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

6.  5-HT7 receptor efficacy distribution throughout the canine stomach.

Authors:  Pieter Janssen; Nicolaas H Prins; Pieter J Peeters; Klaas P Zuideveld; Romain A Lefebvre
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

7.  Expression and function of 5-HT7 receptors in smooth muscle preparations from equine duodenum, ileum, and pelvic flexure.

Authors:  Andrea S Prause; Michael H Stoffel; Christopher J Portier; Meike Mevissen
Journal:  Res Vet Sci       Date:  2009-04-11       Impact factor: 2.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.